Hikma Farmaceutica Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HIKMA FARMACEUTICA, and what generic and branded alternatives to HIKMA FARMACEUTICA drugs are available?
HIKMA FARMACEUTICA has thirty-eight approved drugs.
Drugs and US Patents for Hikma Farmaceutica
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma Farmaceutica | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 065342-001 | Jan 10, 2008 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma Farmaceutica | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 091032-001 | Dec 20, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma Farmaceutica | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 078527-002 | Mar 23, 2009 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma Farmaceutica | CIPROFLOXACIN | ciprofloxacin | INJECTABLE;INJECTION | 076717-002 | Dec 22, 2009 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma Farmaceutica | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065143-001 | Oct 18, 2004 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma Farmaceutica | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 200219-001 | Feb 13, 2013 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.